Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
58.54
-4.95 (-7.80%)
At close: Apr 1, 2025, 4:00 PM
59.31
+0.77 (1.31%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Verona Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4,9753,8001,7092,133444405
Upgrade
Market Cap Growth
122.40%122.40%-19.89%380.79%9.47%435.09%
Upgrade
Enterprise Value
4,8043,5871,4721,907283205
Upgrade
Last Close Price
58.5446.4419.8826.136.727.00
Upgrade
PS Ratio
112.9089.89-4657.4011.09-
Upgrade
PB Ratio
24.2218.586.859.263.002.19
Upgrade
P/TBV Ratio
18.6318.636.879.283.012.20
Upgrade
EV/Sales Ratio
113.6284.83-4164.237.09-
Upgrade
Debt / Equity Ratio
1.121.120.210.050.040.03
Upgrade
Asset Turnover
0.110.11-0.000.21-
Upgrade
Quick Ratio
10.2410.2432.5312.464.9113.82
Upgrade
Current Ratio
10.6310.6333.3312.775.0914.26
Upgrade
Return on Equity (ROE)
-76.42%-76.42%-22.67%-36.30%-33.39%-57.25%
Upgrade
Return on Assets (ROA)
-24.13%-24.13%-14.64%-18.53%-18.45%-31.68%
Upgrade
Return on Capital (ROIC)
-25.72%-25.72%-15.34%-20.93%-20.92%-35.14%
Upgrade
Earnings Yield
-3.49%-4.56%-3.18%-3.22%-12.53%-16.07%
Upgrade
FCF Yield
-2.47%-3.23%-2.94%-2.81%-7.50%-11.14%
Upgrade
Buyback Yield / Dilution
-2.87%-2.86%-19.86%-11.81%-79.97%-149.64%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q